Researchers Submit Patent Application, "Diagnostic Tests", for Approval (USPTO 20230366883).

A patent application has been submitted for a diagnostic test device that can detect anti-dengue virus antibodies. This device aims to identify individuals who have previously been infected with dengue and are seropositive, allowing them to be administered a dengue vaccine. The device uses dengue antigens conjugated to a detectable moiety to detect the presence of binding partners in a biological sample, indicating a dengue infection. The patent application provides detailed descriptions of the test device and its components, as well as the specific sequences and substitutions of the dengue antigens used. This invention could contribute to the prevention and management of dengue disease. [Extracted from the article]